Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Neurosci Bull
2014 Aug 01;304:697-710. doi: 10.1007/s12264-013-1449-1.
Show Gene links
Show Anatomy links
Voltage-dependent blockade by bupivacaine of cardiac sodium channels expressed in Xenopus oocytes.
Zhang H
,
Ji H
,
Liu Z
,
Ji Y
,
You X
,
Ding G
,
Cheng Z
.
???displayArticle.abstract???
Bupivacaine ranks as the most potent and efficient drug among class I local anesthetics, but its high potential for toxic reactions severely limits its clinical use. Although bupivacaine-induced toxicity is mainly caused by substantial blockade of voltage-gated sodium channels (VGSCs), how these hydrophobic molecules interact with the receptor sites to which they bind remains unclear. Nav1.5 is the dominant isoform of VGSCs expressed in cardiac myocytes, and its dysfunction may be the cause of bupivacaine-triggered arrhythmia. Here, we investigated the effect of bupivacaine on Nav1.5 within the clinical concentration range. The electrophysiological measurements on Nav1.5 expressed in Xenopus oocytes showed that bupivacaine induced a voltage- and concentration-dependent blockade on the peak of I Na and the half-maximal inhibitory dose was 4.51 μmol/L. Consistent with other local anesthetics, bupivacaine also induced a use-dependent blockade on Nav1.5 currents. The underlying mechanisms of this blockade may contribute to the fact that bupivacaine not only dose-dependently affected the gating kinetics of Nav1.5 but also accelerated the development of its open-state slow inactivation. These results extend our knowledge of the action of bupivacaine on cardiac sodium channels, and therefore contribute to the safer and more efficient clinical use of bupivacaine.
Bean,
Lidocaine block of cardiac sodium channels.
1983, Pubmed
Bean,
Lidocaine block of cardiac sodium channels.
1983,
Pubmed
Brown,
Regional anesthesia and local anesthetic-induced systemic toxicity: seizure frequency and accompanying cardiovascular changes.
1995,
Pubmed
Burlacu,
Update on local anesthetics: focus on levobupivacaine.
2008,
Pubmed
Candenas,
Molecular diversity of voltage-gated sodium channel alpha and beta subunit mRNAs in human tissues.
2006,
Pubmed
Catterall,
Cellular and molecular biology of voltage-gated sodium channels.
1992,
Pubmed
Catterall,
Structure and function of voltage-gated ion channels.
1995,
Pubmed
Cheng,
Pharmacological modulation of brain Nav1.2 and cardiac Nav1.5 subtypes by the local anesthetic ropivacaine.
2010,
Pubmed
,
Xenbase
Clarkson,
Mechanism for bupivacaine depression of cardiac conduction: fast block of sodium channels during the action potential with slow recovery from block during diastole.
1985,
Pubmed
Eckardt,
Brugada syndrome and supraventricular tachyarrhythmias: a novel association?
2001,
Pubmed
González,
Effects of bupivacaine and a novel local anesthetic, IQB-9302, on human cardiac K+ channels.
2001,
Pubmed
Graf,
The cardiotoxicity of local anesthetics: the place of ropivacaine.
2001,
Pubmed
Gristwood,
Cardiac and CNS toxicity of levobupivacaine: strengths of evidence for advantage over bupivacaine.
2002,
Pubmed
Hanck,
Using lidocaine and benzocaine to link sodium channel molecular conformations to state-dependent antiarrhythmic drug affinity.
2009,
Pubmed
Kindler,
Two-pore domain potassium channels: new sites of local anesthetic action and toxicity.
2005,
Pubmed
Laitinen-Forsblom,
SCN5A mutation associated with cardiac conduction defect and atrial arrhythmias.
2006,
Pubmed
Lenkowski,
Lidocaine block of neonatal Nav1.3 is differentially modulated by co-expression of beta1 and beta3 subunits.
2003,
Pubmed
,
Xenbase
Liu,
Pharmacological kinetics of BmK AS, a sodium channel site 4-specific modulator on Nav1.3.
2012,
Pubmed
,
Xenbase
Nau,
Point mutations at N434 in D1-S6 of mu1 Na(+) channels modulate binding affinity and stereoselectivity of local anesthetic enantiomers.
1999,
Pubmed
Nau,
Point mutations at L1280 in Nav1.4 channel D3-S6 modulate binding affinity and stereoselectivity of bupivacaine enantiomers.
2003,
Pubmed
Ragsdale,
Molecular determinants of state-dependent block of Na+ channels by local anesthetics.
1994,
Pubmed
,
Xenbase
Sakura,
Local anesthetic neurotoxicity does not result from blockade of voltage-gated sodium channels.
1995,
Pubmed
Ulbricht,
Sodium channel inactivation: molecular determinants and modulation.
2005,
Pubmed
Valenzuela,
Stereoselective block of cardiac sodium channels by bupivacaine in guinea pig ventricular myocytes.
1995,
Pubmed
Valenzuela,
Electrophysiologic interactions between mexiletine-quinidine and mexiletine-ropitoin in guinea pig papillary muscle.
1989,
Pubmed
Wang,
SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome.
1995,
Pubmed
Wilde,
Phenotypical manifestations of mutations in the genes encoding subunits of the cardiac sodium channel.
2011,
Pubmed
